Novartis Inflammasome Research, Inc.

United States of America

Create a watch for Novartis Inflammasome Research, Inc.
Total IP 10
Total IP Rank # 157,595
IP Activity Score 0/5.0    0
IP Activity Rank # 1,712,178

Patents

Trademarks

0 0
0 0
10 0
0
 
Last Patent 2021 - Gut-targeted nlrp3 antagonists a...
First Patent 2019 - Methods of treating or selecting...

Latest Inventions, Goods, Services

2020 Invention Compounds and compositions for treating conditions associated with nlrp activity. In one aspect, ...
Invention Gut-targeted nlrp3 antagonists and their use in therapy. Provided herein are gut-targeted NLRP3 a...
2019 Invention The compounds and compositions for treating conditions associated with nlrp activity. In one aspe...
Invention Methods of treating or selecting a treatment for a subject resistant to tnf inhibitor using a nlr...
Invention Nlrp modulators. In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt th...